Products
Names and Compounds of our Products
Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.
| Disease Area | Trademark | Compound | |
|---|---|---|---|
| Migraine | Vyepti® | Eptinezumab | |
| Parkinson's disease | Azilect® | Rasagiline | |
| Alzheimer's disease | Ebixa® | Memantine |
| Disease Area | Trademark | Compound | |
|---|---|---|---|
| Psychosis | Clopixol Depot® | Zuclopenthixoldecanoate | |
| Fluanxol Depot® | Cis(Z)-Flupenticoldecanoate | ||
| Rexulti® | Brexpiprazole | ||
| Depression, Anxiety | Lexapro® | Escitalopram Oxalate | |
| Rexulti® | Brexpiprazole | ||
| Brintellix® | Vortioxetine | ||
| Deanxit® | Flupentixol + melitracene | ||
| Schizophrenia | Abilify Maintena® | Aripiprazole | |
| Bipolar Disorder | Abilify Maintena® | Aripiprazole |
More from lundbeck
Research and Development
R&D of new and improved treatments is at the core of what we do.
Patients
We see patients as people and are committed to support the person behind.
Pipeline
Discover our projects and compounds in development.